Article Dans Une Revue FEBS Letters Année : 2024

The immunological interface: dendritic cells as key regulators in metabolic dysfunction‐associated steatotic liver disease

Résumé

Metabolic dysfunction‐associated steatotic liver disease (MASLD) refers to a broad spectrum of conditions associating fat accumulation in the liver (steatosis) with varying degrees of inflammation (hepatitis) and fibrosis, which can progress to cirrhosis and potentially cancer (hepatocellular carcinoma). The first stages of these diseases are reversible and the immune system, together with metabolic factors (obesity, insulin resistance, Western diet, etc.), can influence the disease trajectory leading to progression or regression. Dendritic cells are professional antigen‐presenting cells that constantly sense environmental stimuli and orchestrate immune responses. Herein, we discuss the existing literature on the heterogeneity of dendritic cell lineages, states, and functions, to provide a comprehensive overview of how liver dendritic cells influence the onset and evolution of MASLD.
Fichier sous embargo
Fichier sous embargo
0 3 20
Année Mois Jours
Avant la publication
jeudi 12 juin 2025
Fichier sous embargo
jeudi 12 juin 2025
Connectez-vous pour demander l'accès au fichier

Dates et versions

hal-04922563 , version 1 (31-01-2025)

Identifiants

Citer

Camilla Klaimi, Wanting Kong, Camille Blériot, Joel Haas. The immunological interface: dendritic cells as key regulators in metabolic dysfunction‐associated steatotic liver disease. FEBS Letters, 2024, ⟨10.1002/1873-3468.15072⟩. ⟨hal-04922563⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More